Signal transduction and modulating pathways in tryptamine-evoked vasopressor responses of the rat isolated perfused mesenteric bed

Vascular Pharmacology

Volumn 58, Issue 1-2, 2013, Pages 140-149

  Anwar, M Akhtar ^a   Ford, William R ^a   Herbert, Amy A ^a   Broadley, Kenneth J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

5 HT2A receptors; Nitric oxide; Rat mesenteric artery; Tryptamine; Vasoconstriction

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NIMESULIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE C; PROSTAGLANDIN SYNTHASE; PROSTANOID RECEPTOR; RHO KINASE; RITANSERIN; SEROTONIN 2A RECEPTOR; TRYPTAMINE;

AMINE TRANSPORT; ANIMAL TISSUE; ARTERY; ARTICLE; CONCENTRATION RESPONSE; MALE; MESENTERIC ARTERY; MESENTERY BLOOD FLOW; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; SHEAR STRESS; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

ANIMALS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RHO-ASSOCIATED KINASES; RITANSERIN; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SIGNAL TRANSDUCTION; TRYPTAMINES; VASOCONSTRICTION; VASODILATION;

EID: 84871716733     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.10.007     Document Type: Article

References (77)

1. 2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem. 1995, 270:445-450.
2. Adkins E.M., Barker E.L., Blakely R.D. Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain 1 in substrate recognition. Mol. Pharmacol. 2001, 59:514-523.
3. 2. Biol. Pharm. Bull. 2004, 28:1174-1178.
4. Andreeva A.V., Vaiskunaite R., Kutuzov M.A., Profirovic J., Skidgel R.A., Voyno-Yasenetskaya T.A. Novel mechanisms of G protein-dependent regulation of endothelial nitric-oxide synthase. Mol. Pharmacol. 2006, 69:975-982.
5. Andreopoulos S., Papapetropoulos A. Molecular aspects of soluble guanylyl cyclase regulation. Gen. Pharmacol. 2000, 34:147-157.
6. Anwar M.A., Ford W.R., Broadley K.J. Mediators regulating tryptamine-induced tone of rat isolated mesenteric arterial bed. Br. Pharmacol. Soc. 2006, (pA2 online 4, 113P).
7. Anwar M.A., Ford W.R., Broadley K.J. Role of cyclooxygenases (COX) metabolites in tryptamine-elicited vasopressor responses in rat isolated mesenteric arterial bed. J. Vasc. Res. 2008, 45(Suppl. 2):109. (PTC2).
8. Anwar M.A., Ford W.R., Broadley K.J., Herbert A.A. Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and β-phenylethylamine. Br. J. Pharmacol. 2012, 165:2191-2202.
9. 2+ sensitization of smooth muscle contraction through activation of Rho-kinase. Pflugers Arch. 2001, 441:596-603.
10. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
11. Blackwell B. Hypertensive crisis due to monoamine-oxidase inhibitors. Lancet 1963, 2:849-850.
12. 2 prostanoid receptor subtypes. Eur. J. Pharmacol. 1997, 340:227-241.
13. Bolla M., You D., Loufrani L., Levy B.I., Levy-Toledano S., Habib A., Henrion D. Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries. Hypertension 2004, 43:1264-1269.
14. Borowsky B., Adham N., Jones K.A., Raddatz R., Artymyshyn R., Ogozalek K.L., Durkin M.M., Lakhlani P.P., Bonini J.A., Pathirana S., Boyle N., Pu X., Kouranova E., Lichtblau H., Ochoa F.Y., Branchek T., Gerald C. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:8966-8971.
15. Bradley P.B., Humphrey P.P.A., Williams R.H. Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors. Br. J. Pharmacol. 1985, 84:919-925.
16. Breyer R.M., Bagdassarian C.K., Myers S.A., Breyer M.D. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 2001, 41:661-690.
17. Broadley K.J. The vascular effects of trace amines and amphetamines. Pharmacol. Ther. 2010, 125:363-375.
18. Broadley K.J., Anwar M.A., Herbert A.A., Fehler M., Jones E.M., Davies W.E., Kidd E.J., Ford W.R. Effects of dietary amines on the gut and its vasculature. Br. J. Nutr. 2009, 101:1645-1652.
19. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis R.E., Amara S.G., Grandy D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 2001, 60:1181-1188.
20. Caramona M.M. Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog. Naunyn Schmiedbergs Arch. Pharmacol. 1982, 319:121-124.
21. Chitaley K., Webb R.C. Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling. Hypertension 2002, 39:438-442.
22. Cockell A.P., Poston L. Isolated mesenteric arteries from pregnant rats show enhanced flow-mediated relaxation but normal myogenic tone. J. Physiol. 1996, 495:545-551.
23. Coleman R.A., Smith W.L., Narumiya S. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 1994, 46:205-229.
24. Coquil J.F., Goridis C., Mack G., Neff N.H. Monoamine oxidase in rat arteries: evidence for different forms and selective localization. Br. J. Pharmacol. 1973, 48:590-599.
25. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 1995, 75:519-560.
26. Eble J.N. A study of the potentiation of tryptamine by monamine oxidase inhibitors in the dog. J. Pharmacol. Exp. Ther. 1965, 148:48-53.
27. Ermert L., Ermert M., Goppelt-Struebe M., Walmrath D., Grimminger F., Steudel W., Ghofrani H.A., Homberger C., Duncker H.-R., Seeger W. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am. J. Respir. Cell Mol. Biol. 1998, 18:479-488.
28. Fehler M., Broadley K.J., Ford W.R., Kidd E.J. Identification of trace amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 382:385-398.
29. Fulep E.E., Vedernikov Y.P., Saade G.R., Garfield R.E. Flow rate-perfusion relationships in situ in the uterine circulation of pregnant rats. Am. J. Obstet. Gynecol. 2002, 186:1022-1026.
30. 2+-sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 2003, 278:1856-1863.
31. Hata A.N., Breyer R.M. Pharmacology and signalling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 2004, 103:147-166.
32. Herbert A.A., Kidd E.J., Broadley K.J. Dietary trace amine-dependent vasoconstriction in porcine coronary artery. Br. J. Pharmacol. 2008, 155:525-534.
33. Hicks P.E., Langer S.Z. Antagonism by tetra-hydro-β-carboline of the vasoconstrictor responses to tryptamine in rat tail arteries. Eur. J. Pharmacol. 1983, 96:145-149.
34. Ho W.-S.V., Randall M.D. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br. J. Pharmacol. 2007, 150:641-651.
35. Hofmann F., Ammendala A., Schlossman J. Rising behind NO:cGMP-dependent protein kinases. J. Cell Sci. 2000, 113:1671-1676.
36. Hristovska A.M., Rasmussen L.E., Hansen P.B., Nielsen S.S., Nüsing R.M., Narumiya S., Vanhoutte P., Skøtt O., Jensen B.L. Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension 2007, 50:525-530.
37. Ishitani R., Kimura M., Takeichi M., Chuang D.-M. Tryptamine induces phosphoinositide turnover and modulates adrenergic and muscarinic cholinergic receptor function in cultured cerebellar granule cells. J. Neurochem. 1994, 63:2080-2085.
38. Jacobs M., Hayakawa K., Swenson L., Bellon S., Fleming M., Taslimi P., Doran J. The structure of dimeric ROCK1 reveals the mechanisms for ligand selectivity. J. Biol. Chem. 2006, 281:260-268.
39. 2γ, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammalian iPLA2s. J. Biol. Chem. 2002, 277:32807-32814.
40. Kuchan M.J., Frangos J.A. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am. J. Physiol. 1994, 266:C628-C636.
41. 2 signaling pathways have different receptor reserves. J. Pharmacol. Exp. Ther. 2003, 304:229-237.
42. Lucas K.A., Pitari G.M., Kazerounians S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 2000, 52:375-413.
43. McGregor D.D. The effect of sympathetic nerve stimulation on vasoconstrictor response in perfused mesenteric blood vessels of the rat. J. Physiol. 1965, 177:21-30.
44. Ming X.F., Viswambharan H., Barandier C., Ruffieux J., Kaibuchi K., Rusconi S., Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol. Cell. Biol. 2002, 22:8467-8477.
45. 2 release from cultured porcine basilar arterial endothelial cells. Vasc. Pharmacol. 2007, 46:85-90.
46. 2β. J. Biol. Chem. 2008, 283:33975-33987.
47. Moreau P., Takase H., Kung C.F., Shaw S., Luscher T.F. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension 1997, 29:763-769.
48. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 1999, 79:1193-1226.
49. Ni W., Thompson J.M., Northcott C.A., Lookingland K., Watts S.W. The serotonin transporter is present and functional in peripheral arterial smooth muscle. J. Cardiovasc. Pharmacol. 2004, 43:770-781.
50. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995, 9:484-496.
51. Osborne N.N., Cutcliffe N., Peard A. Trace amines (ethylamine, octopamine, and tryptamine) stimulate inositol phospholipid hydrolysis in rat cerebral cortex slices. Neurochemistry 1986, 11:1525-1531.
52. Osol G., Laher I., Kelley M. Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am. J. Physiol. 1993, 265:H415-H420.
53. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 2001, 70:281-312.
54. 1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes. Cardiovasc. Res. 2009, 83:148-154.
55. 2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 2000, 275:21722-21729.
56. 2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
57. 3H] Imipramine binding: possible allosteric interaction. J. Neurochem. 1985, 44:349-356.
58. Sewell R.A., Halpern J.H., Pope H.G. Response of cluster headache to psilocybin and LSD. Neurology 2006, 66:1920-1922.
59. Simaan J., Sabra R. In-vivo evidence of a role for nitric oxide in regulating the activity of the norepinephrine transporter. Eur. J. Pharmacol. 2011, 671:102-106.
60. Simmons D.L., Botting R.M., Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004, 56:387-437.
61. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 2003, 83:1325-1358.
62. Stollak J.S., Furchgott R.F. Use of selective anatagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta. J. Pharmacol. Exp. Ther. 1983, 224:215-221.
63. Sugimoto Y., Narumiya S. Prostaglandin E receptors. J. Biol. Chem. 2007, 282:11613-11617.
64. Tang X., Edwards E.M., Holmes B.B., Falck J.R., Campbell W.B. Role of phospholipase C and diacylglyceride lipase pathway in arachidonic acid release and acetylcholine-induced vascular relaxation in rabbit aorta. Am. J. Physiol. 2006, 290:H37-H45.
65. Teixeira C.E., Jin L., Ying Z., Palmer T., Priviero F.B.M., Webb R.C. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery. Clin. Exp. Pharmacol. Physiol. 2005, 32:817-824.
66. Tipton K.F., Boyce S., O'sullivan J., Davey G.P., Healy J. Monoamine oxidases: certainties and uncertainties. Curr. Med. Chem. 2004, 11:1965-1982.
67. Torres G.E., Gainetdinov R.R., Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 2003, 4:13-25.
68. Trappe T.A., Carroll C.C., Jemiolo B., Trappe S.W., Dossing S., Kjae M., Magnusson S.P. Cyclooxygenase mRNA expression in human patellar tendon at rest and after exercise. Am. J. Physiol. 2008, 294:R192-R199.
69. Trendelenburg U. Classification of sympathomimetic amines. Catecholamines, Handbook of Experimental Pharmacology 1972, vol. 33:336-362. Springer-Verlag, Berlin. H. Blaschko, E. Muscholl (Eds.).
70. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., Tamakawa H., Yamagami K., Inui J., Maekawa M., Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
71. Wang A., Nishihashi T., Trandafir C.C., Murakami S., Ji X., Shimizu Y., Kurahashi K. Involvement of endothelial cyclo-oxygenase metabolites in noradrenaline-induced contraction of rat coronary artery. Clin. Exp. Pharmacol. Physiol. 2005, 32:628-632.
72. 2B receptor mediates contraction in the mesenteric artery of mineralcorticoid hypertensive rats. Hypertension 1994, 26:1056-1059.
73. Weissbach H., King W., Sjoersdsma A., Udenfriend S. Formation of indole-3-acetic acid and tryptamine in animals. J. Biol. Chem. 1959, 234:81-86.
74. Williams J., Bogwu J., Oyekan A. The role of the RhoA/Rho-kinase signalling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice. J. Hypertens. 2006, 24:1429-1436.
75. Wollman H., Nilsson E., Antonin K.H., Bieck P.R. Tryptamine kinetics in human volunteers. Neuropsychopharmacology of Trace Amines 1985, 361-378. Humana Press, Clifton, N.J. A.A. Boulton, L. Maitre, P.R. Beick, P. Reiderer (Eds.).
76. 2 and prostacyclin. Br. J. Pharmacol. 2008, 154:1225-1235.
77. Zucchi R., Chiellini G., Scanlan T.S., Grandy D.K. Trace amine-associated receptors and their ligands. Br. J. Pharmacol. 2006, 149:967-978.